Click for best price
Osteoarthritis Pain Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 10100 million
|
Forecast Market size by 2029 |
US$ 14650 million
|
| Growth Rate |
CAGR of 5.5% |
Number of Pages |
123 Pages |
The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers.
This report aims to provide a comprehensive presentation of the global market for Osteoarthritis Pain Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoarthritis Pain Drugs. This report contains market size and forecasts of Osteoarthritis Pain Drugs in global, including the following market information:
Global top five Osteoarthritis Pain Drugs companies in 2022 (%)
The global Osteoarthritis Pain Drugs market was valued at US$ 10100 million in 2022 and is projected to reach US$ 14650 million by 2029, at a CAGR of 5.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Methylcyclohexane market include Pfizer, Johnson & Johnson, GlaxoSmithKline, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Oral is the main type, with a share over 50%. Personal Care is the main application, which holds a share about 90%.
We surveyed the Osteoarthritis Pain Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Osteoarthritis Pain Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Osteoarthritis Pain Drugs Market Segment Percentages, by Type, 2022 (%)
Global Osteoarthritis PaiDrugs n Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Osteoarthritis Pain Drugs Market Segment Percentages, by Application, 2022 (%)
- Medical Care
- Personal Care
Global Osteoarthritis Pain Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Osteoarthritis Pain Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Osteoarthritis Pain Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Osteoarthritis Pain Drugs revenues share in global market, 2022 (%)
- Key companies Osteoarthritis Pain Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Osteoarthritis Pain Drugs sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Bayer
- SK Chemicals
- GSK
- Sanofi
- Crystal Genomics
- Johnson & Johnson
- Sino Biopharmaceutical
- Haohai Biological
- Zhejiang Chengyi Pharmaceutical
- Freda
- Bright Future
- Jingfeng Pharmaceutical
- Chugai Pharmaceutical
- Mikasa Seiyaku
- Taisho Pharmaceutical
- Seikagaku Corporation
- GlaxoSmithKline
- Eli Lilly
- Novartis
- Horizon Pharma
- Abbott
- Mylan
- Daiichi Sankyo
- TEVA
- Almatica Pharma
- Astellas Pharma
- Tide Pharmaceutical
- Iroko Pharmaceuticals
- Hengrui Pharmaceutical
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Osteoarthritis Pain Drugs, market overview.
- Chapter 2: Global Osteoarthritis Pain Drugs market size in revenue and volume.
- Chapter 3: Detailed analysis of Osteoarthritis Pain Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Osteoarthritis Pain Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Osteoarthritis Pain Drugs capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Osteoarthritis Pain Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 10100 million
|
| Forecast Market size by 2029 |
US$ 14650 million
|
| Growth Rate |
CAGR of 5.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
123 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Osteoarthritis Pain Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Osteoarthritis Pain Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Osteoarthritis Pain Drugs Overall Market Size
2.1 Global Osteoarthritis Pain Drugs Market Size: 2022 VS 2029
2.2 Global Osteoarthritis Pain Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Osteoarthritis Pain Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Osteoarthritis Pain Drugs Players in Global Market
3.2 Top Global Osteoarthritis Pain Drugs Companies Ranked by Revenue
3.3 Global Osteoarthritis Pain Drugs Revenue by Companies
3.4 Global Osteoarthritis Pain Drugs Sales by Companies
3.5 Global Osteoarthritis Pain Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Osteoarthritis Pain Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Osteoarthritis Pain Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Osteoarthritis Pain Drugs Players in Global Market
3.8.1 List of Global Tier 1 Osteoarthritis Pain Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Osteoarthritis Pain Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Osteoarthritis Pain Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injection
4.1.4 External
4.2 By Type - Global Osteoarthritis Pain Drugs Revenue & Forecasts
4.2.1 By Type - Global Osteoarthritis Pain Drugs Revenue, 2018-2023
4.2.2 By Type - Global Osteoarthritis Pain Drugs Revenue, 2024-2029
4.2.3 By Type - Global Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Osteoarthritis Pain Drugs Sales & Forecasts
4.3.1 By Type - Global Osteoarthritis Pain Drugs Sales, 2018-2023
4.3.2 By Type - Global Osteoarthritis Pain Drugs Sales, 2024-2029
4.3.3 By Type - Global Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Osteoarthritis Pain Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Osteoarthritis Pain Drugs Market Size, 2022 & 2029
5.1.2 Medical Care
5.1.3 Personal Care
5.2 By Application - Global Osteoarthritis Pain Drugs Revenue & Forecasts
5.2.1 By Application - Global Osteoarthritis Pain Drugs Revenue, 2018-2023
5.2.2 By Application - Global Osteoarthritis Pain Drugs Revenue, 2024-2029
5.2.3 By Application - Global Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Osteoarthritis Pain Drugs Sales & Forecasts
5.3.1 By Application - Global Osteoarthritis Pain Drugs Sales, 2018-2023
5.3.2 By Application - Global Osteoarthritis Pain Drugs Sales, 2024-2029
5.3.3 By Application - Global Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Osteoarthritis Pain Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Osteoarthritis Pain Drugs Market Size, 2022 & 2029
6.2 By Region - Global Osteoarthritis Pain Drugs Revenue & Forecasts
6.2.1 By Region - Global Osteoarthritis Pain Drugs Revenue, 2018-2023
6.2.2 By Region - Global Osteoarthritis Pain Drugs Revenue, 2024-2029
6.2.3 By Region - Global Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Osteoarthritis Pain Drugs Sales & Forecasts
6.3.1 By Region - Global Osteoarthritis Pain Drugs Sales, 2018-2023
6.3.2 By Region - Global Osteoarthritis Pain Drugs Sales, 2024-2029
6.3.3 By Region - Global Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Osteoarthritis Pain Drugs Revenue, 2018-2029
6.4.2 By Country - North America Osteoarthritis Pain Drugs Sales, 2018-2029
6.4.3 US Osteoarthritis Pain Drugs Market Size, 2018-2029
6.4.4 Canada Osteoarthritis Pain Drugs Market Size, 2018-2029
6.4.5 Mexico Osteoarthritis Pain Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Osteoarthritis Pain Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Osteoarthritis Pain Drugs Sales, 2018-2029
6.5.3 Germany Osteoarthritis Pain Drugs Market Size, 2018-2029
6.5.4 France Osteoarthritis Pain Drugs Market Size, 2018-2029
6.5.5 U.K. Osteoarthritis Pain Drugs Market Size, 2018-2029
6.5.6 Italy Osteoarthritis Pain Drugs Market Size, 2018-2029
6.5.7 Russia Osteoarthritis Pain Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Osteoarthritis Pain Drugs Market Size, 2018-2029
6.5.9 Benelux Osteoarthritis Pain Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Osteoarthritis Pain Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Osteoarthritis Pain Drugs Sales, 2018-2029
6.6.3 China Osteoarthritis Pain Drugs Market Size, 2018-2029
6.6.4 Japan Osteoarthritis Pain Drugs Market Size, 2018-2029
6.6.5 South Korea Osteoarthritis Pain Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Osteoarthritis Pain Drugs Market Size, 2018-2029
6.6.7 India Osteoarthritis Pain Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Osteoarthritis Pain Drugs Revenue, 2018-2029
6.7.2 By Country - South America Osteoarthritis Pain Drugs Sales, 2018-2029
6.7.3 Brazil Osteoarthritis Pain Drugs Market Size, 2018-2029
6.7.4 Argentina Osteoarthritis Pain Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Osteoarthritis Pain Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Osteoarthritis Pain Drugs Sales, 2018-2029
6.8.3 Turkey Osteoarthritis Pain Drugs Market Size, 2018-2029
6.8.4 Israel Osteoarthritis Pain Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Osteoarthritis Pain Drugs Market Size, 2018-2029
6.8.6 UAE Osteoarthritis Pain Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Osteoarthritis Pain Drugs Major Product Offerings
7.1.4 Pfizer Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Osteoarthritis Pain Drugs Major Product Offerings
7.2.4 Bayer Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 SK Chemicals
7.3.1 SK Chemicals Company Summary
7.3.2 SK Chemicals Business Overview
7.3.3 SK Chemicals Osteoarthritis Pain Drugs Major Product Offerings
7.3.4 SK Chemicals Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.3.5 SK Chemicals Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK Osteoarthritis Pain Drugs Major Product Offerings
7.4.4 GSK Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GSK Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Osteoarthritis Pain Drugs Major Product Offerings
7.5.4 Sanofi Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Crystal Genomics
7.6.1 Crystal Genomics Company Summary
7.6.2 Crystal Genomics Business Overview
7.6.3 Crystal Genomics Osteoarthritis Pain Drugs Major Product Offerings
7.6.4 Crystal Genomics Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Crystal Genomics Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Osteoarthritis Pain Drugs Major Product Offerings
7.7.4 Johnson & Johnson Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Sino Biopharmaceutical
7.8.1 Sino Biopharmaceutical Company Summary
7.8.2 Sino Biopharmaceutical Business Overview
7.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Major Product Offerings
7.8.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sino Biopharmaceutical Key News & Latest Developments
7.9 Haohai Biological
7.9.1 Haohai Biological Company Summary
7.9.2 Haohai Biological Business Overview
7.9.3 Haohai Biological Osteoarthritis Pain Drugs Major Product Offerings
7.9.4 Haohai Biological Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Haohai Biological Key News & Latest Developments
7.10 Zhejiang Chengyi Pharmaceutical
7.10.1 Zhejiang Chengyi Pharmaceutical Company Summary
7.10.2 Zhejiang Chengyi Pharmaceutical Business Overview
7.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Major Product Offerings
7.10.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Zhejiang Chengyi Pharmaceutical Key News & Latest Developments
7.11 Freda
7.11.1 Freda Company Summary
7.11.2 Freda Osteoarthritis Pain Drugs Business Overview
7.11.3 Freda Osteoarthritis Pain Drugs Major Product Offerings
7.11.4 Freda Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Freda Key News & Latest Developments
7.12 Bright Future
7.12.1 Bright Future Company Summary
7.12.2 Bright Future Osteoarthritis Pain Drugs Business Overview
7.12.3 Bright Future Osteoarthritis Pain Drugs Major Product Offerings
7.12.4 Bright Future Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Bright Future Key News & Latest Developments
7.13 Jingfeng Pharmaceutical
7.13.1 Jingfeng Pharmaceutical Company Summary
7.13.2 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Business Overview
7.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Major Product Offerings
7.13.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Jingfeng Pharmaceutical Key News & Latest Developments
7.14 Chugai Pharmaceutical
7.14.1 Chugai Pharmaceutical Company Summary
7.14.2 Chugai Pharmaceutical Business Overview
7.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Major Product Offerings
7.14.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Chugai Pharmaceutical Key News & Latest Developments
7.15 Mikasa Seiyaku
7.15.1 Mikasa Seiyaku Company Summary
7.15.2 Mikasa Seiyaku Business Overview
7.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Major Product Offerings
7.15.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Mikasa Seiyaku Key News & Latest Developments
7.16 Taisho Pharmaceutical
7.16.1 Taisho Pharmaceutical Company Summary
7.16.2 Taisho Pharmaceutical Business Overview
7.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Major Product Offerings
7.16.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Taisho Pharmaceutical Key News & Latest Developments
7.17 Seikagaku Corporation
7.17.1 Seikagaku Corporation Company Summary
7.17.2 Seikagaku Corporation Business Overview
7.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Major Product Offerings
7.17.4 Seikagaku Corporation Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Seikagaku Corporation Key News & Latest Developments
7.18 GlaxoSmithKline
7.18.1 GlaxoSmithKline Company Summary
7.18.2 GlaxoSmithKline Business Overview
7.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Major Product Offerings
7.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.18.5 GlaxoSmithKline Key News & Latest Developments
7.19 Eli Lilly
7.19.1 Eli Lilly Company Summary
7.19.2 Eli Lilly Business Overview
7.19.3 Eli Lilly Osteoarthritis Pain Drugs Major Product Offerings
7.19.4 Eli Lilly Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Eli Lilly Key News & Latest Developments
7.20 Novartis
7.20.1 Novartis Company Summary
7.20.2 Novartis Business Overview
7.20.3 Novartis Osteoarthritis Pain Drugs Major Product Offerings
7.20.4 Novartis Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Novartis Key News & Latest Developments
7.21 Horizon Pharma
7.21.1 Horizon Pharma Company Summary
7.21.2 Horizon Pharma Business Overview
7.21.3 Horizon Pharma Osteoarthritis Pain Drugs Major Product Offerings
7.21.4 Horizon Pharma Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Horizon Pharma Key News & Latest Developments
7.22 Abbott
7.22.1 Abbott Company Summary
7.22.2 Abbott Business Overview
7.22.3 Abbott Osteoarthritis Pain Drugs Major Product Offerings
7.22.4 Abbott Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Abbott Key News & Latest Developments
7.23 Mylan
7.23.1 Mylan Company Summary
7.23.2 Mylan Business Overview
7.23.3 Mylan Osteoarthritis Pain Drugs Major Product Offerings
7.23.4 Mylan Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.23.5 Mylan Key News & Latest Developments
7.24 Daiichi Sankyo
7.24.1 Daiichi Sankyo Company Summary
7.24.2 Daiichi Sankyo Business Overview
7.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Major Product Offerings
7.24.4 Daiichi Sankyo Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.24.5 Daiichi Sankyo Key News & Latest Developments
7.25 TEVA
7.25.1 TEVA Company Summary
7.25.2 TEVA Business Overview
7.25.3 TEVA Osteoarthritis Pain Drugs Major Product Offerings
7.25.4 TEVA Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.25.5 TEVA Key News & Latest Developments
7.26 Almatica Pharma
7.26.1 Almatica Pharma Company Summary
7.26.2 Almatica Pharma Business Overview
7.26.3 Almatica Pharma Osteoarthritis Pain Drugs Major Product Offerings
7.26.4 Almatica Pharma Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.26.5 Almatica Pharma Key News & Latest Developments
7.27 Astellas Pharma
7.27.1 Astellas Pharma Company Summary
7.27.2 Astellas Pharma Business Overview
7.27.3 Astellas Pharma Osteoarthritis Pain Drugs Major Product Offerings
7.27.4 Astellas Pharma Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.27.5 Astellas Pharma Key News & Latest Developments
7.28 Tide Pharmaceutical
7.28.1 Tide Pharmaceutical Company Summary
7.28.2 Tide Pharmaceutical Business Overview
7.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Major Product Offerings
7.28.4 Tide Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.28.5 Tide Pharmaceutical Key News & Latest Developments
7.29 Iroko Pharmaceuticals
7.29.1 Iroko Pharmaceuticals Company Summary
7.29.2 Iroko Pharmaceuticals Business Overview
7.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Major Product Offerings
7.29.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.29.5 Iroko Pharmaceuticals Key News & Latest Developments
7.30 Hengrui Pharmaceutical
7.30.1 Hengrui Pharmaceutical Company Summary
7.30.2 Hengrui Pharmaceutical Business Overview
7.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Major Product Offerings
7.30.4 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales and Revenue in Global (2018-2023)
7.30.5 Hengrui Pharmaceutical Key News & Latest Developments
8 Global Osteoarthritis Pain Drugs Production Capacity, Analysis
8.1 Global Osteoarthritis Pain Drugs Production Capacity, 2018-2029
8.2 Osteoarthritis Pain Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Osteoarthritis Pain Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Osteoarthritis Pain Drugs Supply Chain Analysis
10.1 Osteoarthritis Pain Drugs Industry Value Chain
10.2 Osteoarthritis Pain Drugs Upstream Market
10.3 Osteoarthritis Pain Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Osteoarthritis Pain Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Osteoarthritis Pain Drugs in Global Market
Table 2. Top Osteoarthritis Pain Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Osteoarthritis Pain Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Osteoarthritis Pain Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Osteoarthritis Pain Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Osteoarthritis Pain Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Osteoarthritis Pain Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Osteoarthritis Pain Drugs Product Type
Table 9. List of Global Tier 1 Osteoarthritis Pain Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Osteoarthritis Pain Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Osteoarthritis Pain Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Osteoarthritis Pain Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Osteoarthritis Pain Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Osteoarthritis Pain Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Osteoarthritis Pain Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Osteoarthritis Pain Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Osteoarthritis Pain Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Osteoarthritis Pain Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Osteoarthritis Pain Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Osteoarthritis Pain Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Osteoarthritis Pain Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Osteoarthritis Pain Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Osteoarthritis Pain Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Osteoarthritis Pain Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Osteoarthritis Pain Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Osteoarthritis Pain Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Osteoarthritis Pain Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Osteoarthritis Pain Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Osteoarthritis Pain Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Osteoarthritis Pain Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Osteoarthritis Pain Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Osteoarthritis Pain Drugs Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Osteoarthritis Pain Drugs Product Offerings
Table 48. Pfizer Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Osteoarthritis Pain Drugs Product Offerings
Table 52. Bayer Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Bayer Key News & Latest Developments
Table 54. SK Chemicals Company Summary
Table 55. SK Chemicals Osteoarthritis Pain Drugs Product Offerings
Table 56. SK Chemicals Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. SK Chemicals Key News & Latest Developments
Table 58. GSK Company Summary
Table 59. GSK Osteoarthritis Pain Drugs Product Offerings
Table 60. GSK Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. GSK Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Osteoarthritis Pain Drugs Product Offerings
Table 64. Sanofi Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Crystal Genomics Company Summary
Table 67. Crystal Genomics Osteoarthritis Pain Drugs Product Offerings
Table 68. Crystal Genomics Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Crystal Genomics Key News & Latest Developments
Table 70. Johnson & Johnson Company Summary
Table 71. Johnson & Johnson Osteoarthritis Pain Drugs Product Offerings
Table 72. Johnson & Johnson Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Johnson & Johnson Key News & Latest Developments
Table 74. Sino Biopharmaceutical Company Summary
Table 75. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Offerings
Table 76. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Sino Biopharmaceutical Key News & Latest Developments
Table 78. Haohai Biological Company Summary
Table 79. Haohai Biological Osteoarthritis Pain Drugs Product Offerings
Table 80. Haohai Biological Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Haohai Biological Key News & Latest Developments
Table 82. Zhejiang Chengyi Pharmaceutical Company Summary
Table 83. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Offerings
Table 84. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Zhejiang Chengyi Pharmaceutical Key News & Latest Developments
Table 86. Freda Company Summary
Table 87. Freda Osteoarthritis Pain Drugs Product Offerings
Table 88. Freda Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Freda Key News & Latest Developments
Table 90. Bright Future Company Summary
Table 91. Bright Future Osteoarthritis Pain Drugs Product Offerings
Table 92. Bright Future Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Bright Future Key News & Latest Developments
Table 94. Jingfeng Pharmaceutical Company Summary
Table 95. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Offerings
Table 96. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Jingfeng Pharmaceutical Key News & Latest Developments
Table 98. Chugai Pharmaceutical Company Summary
Table 99. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Offerings
Table 100. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Chugai Pharmaceutical Key News & Latest Developments
Table 102. Mikasa Seiyaku Company Summary
Table 103. Mikasa Seiyaku Osteoarthritis Pain Drugs Product Offerings
Table 104. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Mikasa Seiyaku Key News & Latest Developments
Table 106. Taisho Pharmaceutical Company Summary
Table 107. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Offerings
Table 108. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Taisho Pharmaceutical Key News & Latest Developments
Table 110. Seikagaku Corporation Company Summary
Table 111. Seikagaku Corporation Osteoarthritis Pain Drugs Product Offerings
Table 112. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Seikagaku Corporation Key News & Latest Developments
Table 114. GlaxoSmithKline Company Summary
Table 115. GlaxoSmithKline Osteoarthritis Pain Drugs Product Offerings
Table 116. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. GlaxoSmithKline Key News & Latest Developments
Table 118. Eli Lilly Company Summary
Table 119. Eli Lilly Osteoarthritis Pain Drugs Product Offerings
Table 120. Eli Lilly Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Eli Lilly Key News & Latest Developments
Table 122. Novartis Company Summary
Table 123. Novartis Osteoarthritis Pain Drugs Product Offerings
Table 124. Novartis Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Novartis Key News & Latest Developments
Table 126. Horizon Pharma Company Summary
Table 127. Horizon Pharma Osteoarthritis Pain Drugs Product Offerings
Table 128. Horizon Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 129. Horizon Pharma Key News & Latest Developments
Table 130. Abbott Company Summary
Table 131. Abbott Osteoarthritis Pain Drugs Product Offerings
Table 132. Abbott Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 133. Abbott Key News & Latest Developments
Table 134. Mylan Company Summary
Table 135. Mylan Osteoarthritis Pain Drugs Product Offerings
Table 136. Mylan Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 137. Mylan Key News & Latest Developments
Table 138. Daiichi Sankyo Company Summary
Table 139. Daiichi Sankyo Osteoarthritis Pain Drugs Product Offerings
Table 140. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 141. Daiichi Sankyo Key News & Latest Developments
Table 142. TEVA Company Summary
Table 143. TEVA Osteoarthritis Pain Drugs Product Offerings
Table 144. TEVA Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 145. TEVA Key News & Latest Developments
Table 146. Almatica Pharma Company Summary
Table 147. Almatica Pharma Osteoarthritis Pain Drugs Product Offerings
Table 148. Almatica Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 149. Almatica Pharma Key News & Latest Developments
Table 150. Astellas Pharma Company Summary
Table 151. Astellas Pharma Osteoarthritis Pain Drugs Product Offerings
Table 152. Astellas Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 153. Astellas Pharma Key News & Latest Developments
Table 154. Tide Pharmaceutical Company Summary
Table 155. Tide Pharmaceutical Osteoarthritis Pain Drugs Product Offerings
Table 156. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 157. Tide Pharmaceutical Key News & Latest Developments
Table 158. Iroko Pharmaceuticals Company Summary
Table 159. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Offerings
Table 160. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 161. Iroko Pharmaceuticals Key News & Latest Developments
Table 162. Hengrui Pharmaceutical Company Summary
Table 163. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Offerings
Table 164. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 165. Hengrui Pharmaceutical Key News & Latest Developments
Table 166. Osteoarthritis Pain Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 167. Global Osteoarthritis Pain Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 168. Global Osteoarthritis Pain Drugs Production by Region, 2018-2023 (K Units)
Table 169. Global Osteoarthritis Pain Drugs Production by Region, 2024-2029 (K Units)
Table 170. Osteoarthritis Pain Drugs Market Opportunities & Trends in Global Market
Table 171. Osteoarthritis Pain Drugs Market Drivers in Global Market
Table 172. Osteoarthritis Pain Drugs Market Restraints in Global Market
Table 173. Osteoarthritis Pain Drugs Raw Materials
Table 174. Osteoarthritis Pain Drugs Raw Materials Suppliers in Global Market
Table 175. Typical Osteoarthritis Pain Drugs Downstream
Table 176. Osteoarthritis Pain Drugs Downstream Clients in Global Market
Table 177. Osteoarthritis Pain Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Osteoarthritis Pain Drugs Segment by Type in 2022
Figure 2. Osteoarthritis Pain Drugs Segment by Application in 2022
Figure 3. Global Osteoarthritis Pain Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Osteoarthritis Pain Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Osteoarthritis Pain Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Osteoarthritis Pain Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Osteoarthritis Pain Drugs Revenue in 2022
Figure 9. By Type - Global Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Osteoarthritis Pain Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Osteoarthritis Pain Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Osteoarthritis Pain Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
Figure 23. US Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
Figure 28. Germany Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
Figure 37. China Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Osteoarthritis Pain Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Osteoarthritis Pain Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Osteoarthritis Pain Drugs by Region, 2022 VS 2029
Figure 54. Osteoarthritis Pain Drugs Industry Value Chain
Figure 55. Marketing Channels
